Expertise in
13
conditions

Sophie Susen

Lille, FR 
Expertise in
13
conditions
Lille, FR 

Overview

Sophie Susen practices practicing medicine in Lille, France.

Ms. Susen is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Von Willebrand Disease (VWD), Blood Clots, Hemophilia A, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

She is actively involved in clinical research, co-authoring 171 peer reviewed articles and participating in 8 clinical trials.

Gender

Female

Locations

Lille, 59000, France
Other Locations
Caen, France
Bordeaux, France
Paris, France
France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Haemophilia and Bone Loss PHILEOS Study
Haemophilia and Bone Loss PHILEOS Study
Enrollment Status: Completed
Publish Date: June 03, 2026
Intervention Type: Biological, Radiation
Study Phase: Not Applicable
A Clinico-biological Database on Atypical Venous Thrombosis in the Context of anticovid19 Vaccination
A Clinico-biological Database on Atypical Venous Thrombosis in the Context of anticovid19 Vaccination
Enrollment Status: Withdrawn
Publish Date: May 22, 2026
Intervention Type: Other
A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease
A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease
Enrollment Status: Completed
Publish Date: May 15, 2026
Intervention Type: Biological
Study Drugs: Von Willebrand Factor, Factor VIII
Study Phase: Phase 3
A Global, Open-Label, Multicenter, Phase 1/2 Study of the Safety and Dose Escalation of BAX 888, an Adeno-Associated Virus Serotype 8 (AAV8) Vector Expressing B-Domain Deleted Factor VIII (BDD-FVIII) in Severe Hemophilia A Subjects Administered a Single Intravenous Infusion
A Global, Open-Label, Multicenter, Phase 1/2 Study of the Safety and Dose Escalation of BAX 888, an Adeno-Associated Virus Serotype 8 (AAV8) Vector Expressing B-Domain Deleted Factor VIII (BDD-FVIII) in Severe Hemophilia A Subjects Administered a Single Intravenous Infusion
Enrollment Status: Completed
Publish Date: September 11, 2025
Intervention Type: Drug
Study Drug: BAX-888 Adeno-Associated Virus Serotype 8 Vector B-Domain Deleted Factor VIII Vaccine
Study Phase: Phase 1/Phase 2
Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)
Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Biological
Study Drugs: PEG-Factor VIII, Eloctate ITI
Study Phase: Phase 3
An Interventional Randomized Controlled Trial of the Quantra® System With the QStat® Cartridge in Trauma
An Interventional Randomized Controlled Trial of the Quantra® System With the QStat® Cartridge in Trauma
Enrollment Status: Terminated
Publish Date: March 14, 2025
Intervention Type: Diagnostic test
PCR-COVID-19 Predictors of Positivity in Patients Admitted to ICU for Respiratory Infection: A Prospective Observational Cohort Study
PCR-COVID-19 Predictors of Positivity in Patients Admitted to ICU for Respiratory Infection: A Prospective Observational Cohort Study
Enrollment Status: Completed
Publish Date: December 06, 2023
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Other
View 7 Less Clinical Trials

171 Total Publications

Soluble ST2 dynamics are associated with delayed hospital discharge in COVID-19 patients: a joint-modeling analysis of the DisCoVeRy trial's longitudinal data.
Soluble ST2 dynamics are associated with delayed hospital discharge in COVID-19 patients: a joint-modeling analysis of the DisCoVeRy trial's longitudinal data.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: June 01, 2026

Frequently Asked Questions about Sophie Susen

Is Sophie Susen a top-rated expert for Von Willebrand Disease (VWD)?

MediFind is an objective health platform that identifies experts based on real-world data. Sophie Susen is classified as an Elite expert for Von Willebrand Disease (VWD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sophie Susen participate in research or clinical trials?

Yes. Sophie Susen has published 171 articles and abstracts on conditions like Von Willebrand Disease (VWD). You can view a list of Sophie Susen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Susen's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 29 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile